128 related articles for article (PubMed ID: 24463279)
1. Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy.
Johnson K; Boucher HW
Clin Infect Dis; 2014 May; 58(9):1284-6. PubMed ID: 24463279
[No Abstract] [Full Text] [Related]
2. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Satlin MJ; Jenkins SG; Walsh TJ
Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Enterobacteriaceae: a potential threat.
Schwaber MJ; Carmeli Y
JAMA; 2008 Dec; 300(24):2911-3. PubMed ID: 19109119
[No Abstract] [Full Text] [Related]
4. Measuring Carbapenem-Resistant Enterobacteriaceae in the United States: A Critical Step for Control.
Hayden MK
JAMA; 2015 Oct; 314(14):1455-6. PubMed ID: 26436518
[No Abstract] [Full Text] [Related]
5. United States Centers for Disease Control and Prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae.
Kallen A; Guh A
Euro Surveill; 2012 Jun; 17(26):. PubMed ID: 22790535
[No Abstract] [Full Text] [Related]
6. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.
Pouch SM; Satlin MJ
Virulence; 2017 May; 8(4):391-402. PubMed ID: 27470662
[TBL] [Abstract][Full Text] [Related]
7. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Satlin MJ; Calfee DP; Chen L; Fauntleroy KA; Wilson SJ; Jenkins SG; Feldman EJ; Roboz GJ; Shore TB; Helfgott DC; Soave R; Kreiswirth BN; Walsh TJ
Leuk Lymphoma; 2013 Apr; 54(4):799-806. PubMed ID: 22916826
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
Martirosov DM; Lodise TP
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
[TBL] [Abstract][Full Text] [Related]
10. CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens.
García-Fernández S; Hernández-García M; Valverde A; Ruiz-Garbajosa P; Morosini MI; Cantón R
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):207-209. PubMed ID: 27916545
[TBL] [Abstract][Full Text] [Related]
11.
Mohanty S; Gaind R
Indian J Med Microbiol; 2016; 34(4):558-560. PubMed ID: 27934845
[No Abstract] [Full Text] [Related]
12. Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon.
Kanafani ZA; Kmeid J; Nawar T; Assaf SM; Zahreddine N; Kanj SS
Int J Antimicrob Agents; 2016 May; 47(5):415-6. PubMed ID: 27155945
[No Abstract] [Full Text] [Related]
13. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):290-1. PubMed ID: 22521054
[No Abstract] [Full Text] [Related]
14. Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in Northern Taiwan.
Hsieh WS; Wang NY; Feng JA; Weng LC; Wu HH
J Antimicrob Chemother; 2014 Oct; 69(10):2871-3. PubMed ID: 25140578
[No Abstract] [Full Text] [Related]
15. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
16. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
Martin ET; Tansek R; Collins V; Hayakawa K; Abreu-Lanfranco O; Chopra T; Lephart PR; Pogue JM; Kaye KS; Marchaim D
Am J Infect Control; 2013 Feb; 41(2):180-2. PubMed ID: 22939417
[TBL] [Abstract][Full Text] [Related]
17. Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.
Watkins RR; Bonomo RA
Expert Rev Anti Infect Ther; 2013 Jun; 11(6):543-5. PubMed ID: 23750724
[No Abstract] [Full Text] [Related]
18. Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
Nabarro LE; Veeraraghavan B
Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2307-11. PubMed ID: 26363636
[TBL] [Abstract][Full Text] [Related]
19. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
Murray PR
MLO Med Lab Obs; 2013 May; 45(5):26, 28, 30. PubMed ID: 23763046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
